ISPE GAMP 5 Category 4 Software: CSV vs CSA Risk-Based Validation Guide for Pharma

The International Society for Pharmaceutical Engineering (ISPE) GAMP 5 framework classifies software to determine the appropriate validation rigor: • Category 1: Infrastructure software (operating systems, database engines). • Category 3: Non-configured off-the-shelf software. • Category 4: Configured software (e.g., Novaqis DMS, LIMS, LMS, QMS, BRM) where standard platform capabilities are tailored to site SOPs without altering underlying source code. • Category 5: Custom bespoke software developed from scratch (highest risk and maintenance cost).

Choosing Category 4 configurable platforms dramatically reduces validation timelines compared to bespoke Category 5 builds.

Traditional CSV often suffers from document-heavy, linear testing that focuses on testing non-critical functions to produce compliance paper rather than ensuring quality. The US FDA's modern Computer Software Assurance (CSA) paradigm shifts focus to risk-based testing, unscripted exploratory testing, and leveraging vendor automated testing evidence.

Key pillars of modern validation include: • Critical Quality Attributes (CQA) Focus: Concentrating rigorous verification on direct product quality and data integrity risks (e.g. e-signatures, calculation formulas, audit trails). • Automated Regression Testing: Utilizing vendor-executed automated test runs to eliminate repetitive manual re-testing during software version upgrades.

Novaqis delivers executed, pre-configured GAMP 5 Category 4 validation packages including User Requirement Specifications (URS), Functional Specifications (FS), Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ) test execution protocols, and Requirements Traceability Matrices (RTM), compressing typical 6-month CSV cycles into 3–4 weeks.